Overview Noble Corporation plc (NYSE: NE) is an offshore drilling contractor for the oil and gas industry. The company focuses on ultra-deepwater and ...
Exelixis, Positive News from Celestial Study, Cabometyx Label Review Due February 15, 2018
Company Overview Exelixis, Inc. (NASDAQ: EXEL) is a pharmaceutical company that develops and commercializes medicines to improve care and outcomes for...
Rigel Pharmaceuticals, Fostamatinib Clinical Trials Update, and Recent Capital Raise
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is a biotechnology company dedicated to discovering, developing, and providing novel small molecule drugs t...
Aptevo Therapeutics, ADAPTIR Platform and Recent Drug Asset Sale
Aptevo Therapeutics Inc. (NASDAQ: APVO) is a clinical-stage biotechnology company focused on novel oncology and hematology therapeutics to improve pat...
Endocyte, Wedbush Analyst Upgrade, and the PSMA-617 Licensing Deal
Endocyte, Inc. (NASDAQ: ECYT) is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. Endocyte uses dr...
ENSCO PLC, Completes Atwood Acquisition and Gets Analyst’s Upgrade
Ensco PLC, (NYSE: ESV) operates through three segments: Floaters, Jackups, and Other. The company owns and operates an offshore drilling rig fleet in ...
Immune Exits Oncology and Narrows its Focus on Two Promising Drugs
Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and in...
Keryx Has Upcoming PDUFA Action on Label Expansion for Auryxia
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), with headquarters in Boston, Massachusetts, is a commercial-stage company focused on bringing innovativ...
Mylan, Approval of Copaxone Should Provide an Accretive Boost, Generic Advair Next?
Company Overview Mylan N.V. (NASDAQ: MYL) is a global pharmaceutical company. The company develops, licenses, manufactures, markets, and distributes g...
Positive Outlook for FDA Approval of Zilretta, Marketing Preparations Underway
Company Overview Flexion Therapeutics, Inc. (NASDAQ: FLXN) is a specialty pharmaceutical company that develops treatments for musculoskeletal conditio...